Ben Collman

Ben Collman has extensive experience in drug product manufacturing and formulation development, currently serving as VP of Drug Product Manufacturing at BridgeBio since March 2019. Prior roles include Executive Director at Eidos Therapeutics, with additional positions as Senior Director and Director of Formulation Development. Collman has held senior scientific roles at Ardelyx, Inc., Gilead Sciences, AbbVie, Abbott Laboratories, and Pfizer Pharmaceuticals, focusing on various formulation techniques such as wet granulation, direct compression, amorphous solid dispersions, hot melt extrusion, and controlled release. Collman’s educational background includes studies at Eastern Michigan University and Hope College from 1996 to 1998.